Alcohol-induced alterations in cell function, hepatic inflammation, and fibrosis are prominent features of liver disease in general and of alcoholic liver injury in particular. The link between these processes, however, remains unclear. A virtually universal characteristic of liver injury and subsequent inflammation is the induction of hepatocellular damage, and work from our laboratory has extensively studied the effect of ethanol administration on the hepatocyte and the process of endocytosis by these cells, using the asialoglycoprotein receptor (ASGP-R) pathway as a model. Our recent studies have shown that impaired uptake of several ligands by the ASGP-R (cellular fibronectin, carcinoembryonic antigen, and apoptotic bodies) leads to an ethanol-induced accumulation which then contributes to enhanced activation and cytokine production by non-parenchymal cells such as Kupffer cells and liver endothelial cells. The interaction of these ligands with the sinusoidal cells of the liver, as well as the cooperation and regulation between the different cell types after ethanol administration warrants further investigation and is the focus of talk. In our work we aim to acquire a better understanding of the crossinteractive associations that occur between the cell types following chronic ethanol administration, and which contribute to inflammation.
Alcohol-induced alterations in cell function, hepatic inflammation, and fibrosis are prominent features of liver disease in general and of alcoholic liver injury in particular. The link between these processes, however, remains unclear. A virtually universal characteristic of liver injury and subsequent inflammation is the induction of hepatocellular damage, and work from our laboratory has extensively studied the effect of ethanol administration on the hepatocyte and the process of endocytosis by these cells, using the asialoglycoprotein receptor (ASGP-R) pathway as a model. Our recent studies have shown that impaired uptake of several ligands by the ASGP-R (cellular fibronectin, carcinoembryonic antigen, and apoptotic bodies) leads to an ethanol-induced accumulation which then contributes to enhanced activation and cytokine production by non-parenchymal cells such as Kupffer cells and liver endothelial cells. The interaction of these ligands with the sinusoidal cells of the liver, as well as the cooperation and regulation between the different cell types after ethanol administration warrants further investigation and is the focus of talk. In our work we aim to acquire a better understanding of the crossinteractive associations that occur between the cell types following chronic ethanol administration, and which contribute to inflammation. Alcohol-induced inflammation plays an important part in the induction of alcohol induced brain damage. Increased peripheral inflammation, with the production of pro-inflammatory cytokines, possibly as a result of bacterial interaction with alcohol, acetaldehyde toxicity, macrophage stimulation or other factors, may act as important chemical messengers, which are able to traverse the blood brain barrier, BBB, and affect central nervous system function. Indeed in adolescent binge drinkers, changes in the plasma ratios of pro-inflammatory to anti-inflammatory cytokines are eviden. Once these cytokines have crossed the BBB, they may interact with receptors on glial cells thus enhancing the production of pro-inflammatory mediators which may lead to cognitive dysfunction. Since glial cells play an important role in the removal of neurotransmitter at the synaptic cleft, their activation may adversely affect this process thereby further contributing to cognitive dysfunction and depression. In addition increased glutamate excitotoxicity, as a result of alcohol detoxification, may contribute to the pro-inflammatory milieu. Animal studies have shown that the suppression of such an inflammatory response in the brain induced by chronic alcohol abuse and binge drinking by the administration of taurine analogues is beneficial in reducing both the inflammation and excessive glutamate production. Drug addiction is a chronically relapsing disorder. Susceptibility to relapse can be traced to multiple factors: craving elicited by drug-related cues, anxiety, hypersensitivity to stress, and impaired impulse control. Relapse prevention treatments that concurrently target these vulnerability states may offer significant clinical advantages. Cannabidiol (CBD), the main non-psychoactive component of cannabis sativa, may provide such a profile of actions. CBD reduced ethanol and cocaine seeking in animal models of relapse during 7-days of treatment. Remarkably, drug seeking remained fully attenuated as late as 5 months after treatment termination. CBD also reduced anxiety-like behavior as measured in the elevated plus maze test, both during and after CBD treatment. Finally CBD reversed high impulsivity, measured by a delay discounting task, in
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